Article
Publicly Available
Frontmatter
Published/Copyright:
August 13, 2020
Published Online: 2020-08-13
Published in Print: 2020-08-27
©2020 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Production of 67Cu by enriched 70Zn targets: first measurements of formation cross sections of 67Cu, 64Cu, 67Ga, 66Ga, 69mZn and 65Zn in interactions of 70Zn with protons above 45 MeV
- Highly efficient separation of ruthenium from alkaline radioactive feeds using an anion exchange resin
- Selective Cs-removal from highly acidic spent nuclear fuel solutions
- Separation and quantification of 90Sr from ion-exchange resin radioactive waste: methods and techniques of analysis
- Separation of radiosilver from a cyclotron-irradiated palladium target
- A novel ionic liquid-impregnated chitosan application for separation and purification of fission 99Mo from alkaline solution
- Formulation of ‘ready-to-use’ human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using moderate specific activity 177Lu and its preliminary evaluation in human patient
- Possible use of tetrabromophenolphthalein ethyl ester as a liquid dosimeter
Articles in the same Issue
- Frontmatter
- Production of 67Cu by enriched 70Zn targets: first measurements of formation cross sections of 67Cu, 64Cu, 67Ga, 66Ga, 69mZn and 65Zn in interactions of 70Zn with protons above 45 MeV
- Highly efficient separation of ruthenium from alkaline radioactive feeds using an anion exchange resin
- Selective Cs-removal from highly acidic spent nuclear fuel solutions
- Separation and quantification of 90Sr from ion-exchange resin radioactive waste: methods and techniques of analysis
- Separation of radiosilver from a cyclotron-irradiated palladium target
- A novel ionic liquid-impregnated chitosan application for separation and purification of fission 99Mo from alkaline solution
- Formulation of ‘ready-to-use’ human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using moderate specific activity 177Lu and its preliminary evaluation in human patient
- Possible use of tetrabromophenolphthalein ethyl ester as a liquid dosimeter